What's breaking now, across thousands of outlets.
(RTTNews) - Japanese drugmaker Astellas Pharma Inc. (ALPMY) announced on Thursday that it has entered into a clinical trial collaboration and supply agreement with Immuneering Corp. (IMRX) to evaluate combination therapies for pancreatic cancer patients, whose tumors express CLDN
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Construction begins in December and is expected to take around three months.
Min, 16, says people do not always understand her sacrifices and how valuable support is.
Medical staff are going unpaid, lack proper training and are struggling with shortages of essential supplies, MSF warns
Getting a vaccine to a child starts long before anyone loads a cold box. It starts with knowing the child’s community exists.
The Pharmaceutical Society of Nigeria (PSN) and the Association of Community Pharmacists of Nigeria (ACPN), Edo State chapters, have condemned alleged unlawful raids, arbitrary arrests, seizure of…
Be kind to yourself. Don't miss a story, subscribe here.
